BioSpace News Archive

The Canadian Medical Protective Association (CMPA) led an engaging discussion on Artificial intelligence (AI) in healthcare today in Toronto during its Annual Meeting and Conference.

The Delta Dental Community Care Foundation announced the recipients of its annual Delta Dental Student Leadership Awards. 29 exceptional dental school students from across the U.S. will each receive $10,000 in recognition of their leadership abilities and dedication to providing dental care and oral health education to the various communities in which Delta Dental serves.

Kibow® Biotech, Inc. is excited to feature RENADYL™, an all-natural probiotic formulation for kidney health, during the 2019 The American Association of Naturopathic Physicians Convention from August 15-17 at the Oregon Convention Center.

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today reported financial results for the second quarter ended June 30, 2019 and provided an update on its business.

Dr. Amen and Amen Clinics physicians will address how neuroscience is disrupting psychiatry and helping to prevent or reverse mental health issues

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for its Intravaginal Culture System, INVOcell®, today announced financial results for the second quarter of 2019, ended June 30, 2019.

The Alliance to Prevent Legionnaires’ Disease issued the following statement in response to the release of the Management of Legionella in Water Systems report from the National Academies of Sciences, Engineering, and Medicine

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today reported financial results for the three and six months ended June 30, 2019 and provided a corporate update, including the announcement of a new Board member, Dr. Louis G. Lange.

It’s the first advancement in surgical hardware technology in three decades. Dallas based Medcillary has been selected as part of a worldwide team of distributors bringing it to market.

Dr. Jo Varshney, a multi-disciplinary and celebrated leader in veterinary and human health development, along with a team of world class scientists and engineers in machine learning and in silico simulation bring clarity to drug development through better science.